Email Updates

You are here

mAb 2C7 + TDF IVR

Status
Ongoing
Phase
Open Label
Principal Investigator(s)
RAM, SANJAY
Objective

This collaborative proposal between UMass, Planet Biotechnology, Inc., Oak Crest Institute of Science and MassBiologics seeks to develop intravaginal rings (IVRs) to deliver fully humanized mAb 2C7 in combination with tenofovir disoproxil fumarate (intravaginal TDF; proven efficacious in preventing HIV transmission to women) to prevent gonorrhea and HIV infections.

Prevention Option(s)
Microbicides
Arms and Assigned Interventions
Products
TDF
Product Developers
MassBiologics; Oak Crest Institute of Science; Planet Biotechnology, Inc.; University of Massachusetts
April 2018
March 2023
Population
Men